id:"swepub:oai:DiVA.org:uu-100425"
Search: id:"swepub:oai:DiVA.org:uu-100425" > Role of MAPK in apo...
- 1 of 1
- Previous record
- Next record
- To hitlist
- Sol, E-ri MUppsala universitet,Institutionen för medicinsk cellbiologi (author)
Role of MAPK in apolipoprotein CIII-induced apoptosis in INS-1E cells
- Article/chapterEnglish2009
Publisher, publication year, extent ...
- 2009
- printrdacarrier
Numbers
- LIBRIS-ID:oai:DiVA.org:uu-100425
- https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-100425URI
- https://doi.org/10.1186/1476-511X-8-3DOI
Supplementary language notes
- Language:English
- Summary in:English
Part of subdatabase
- SwePubSwePub
Classification
Notes
- BACKGROUND: Individuals with type 2 diabetes mellitus (T2DM) have elevated levels of circulating apolipoprotein CIII (apoCIII). ApoCIII plays an important role for plasma triglyceride levels and elevated levels of the apolipoprotein have been connected with dyslipidemia in T2DM subjects. In addition, apoCIII has been linked to enhanced beta-cell apoptosis. The present study was undertaken to investigate apoptotic mechanisms induced by the apolipoprotein. RESULTS: ApoCIII (10 microg/ml) enhanced apoptosis 2-fold in insulin-producing INS-1E cells after 24 hours exposure to the apolipoprotein. At this time point phosphorylation of mitogen activated protein kinase (MAPK) p38 had doubled but ERK1/2 and JNK were not activated. Instead, ERK1/2 showed rapid and transient phosphorylation (2-fold after 0.5 hour). No JNK phosphorylation was observed. In support of a role of activation of not only p38 but also ERK1/2 in apoCIII-induced apoptosis, inclusion of p38 inhibitor SB203580 (10 microM) or ERK1/2 inhibitor PD98059 (100 microM) normalized apoptosis. Whereas influx of Ca2+ was linked to apoCIII-induced ERK1/2 activation, pro-apoptotic protein CHOP/GADD of the unfolded protein response (UPR) was not affected by apoCIII. CONCLUSION: It is suggested that elevated circulating apoCIII levels may contribute to beta-cell apoptosis via activation of p38 and ERK1/2 in individuals with T2DM. Therapies aiming at normalizing levels of apoCIII could be beneficial not only for the function of the beta-cell but also for cardiovascular protection.
Subject headings and genre
- MEDICINE
- MEDICIN
Added entries (persons, corporate bodies, meetings, titles ...)
- Sundsten, TeaUppsala universitet,Institutionen för medicinsk cellbiologi (author)
- Bergsten, PeterUppsala universitet,Institutionen för medicinsk cellbiologi(Swepub:uu)peteberg (author)
- Uppsala universitetInstitutionen för medicinsk cellbiologi (creator_code:org_t)
Related titles
- In:Lipids in Health and Disease8, s. 3-1476-511X
Internet link
Find in a library
- Lipids in Health and Disease (Search for host publication in LIBRIS)
To the university's database
- 1 of 1
- Previous record
- Next record
- To hitlist
Find more in SwePub
- By the author/editor
- Sol, E-ri M
- Sundsten, Tea
- Bergsten, Peter
- Articles in the publication
- Lipids in Health ...
- By the university
- Uppsala University
Search outside SwePub
- Extend your search to:
- Google Book Search
- Google Scholar
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
- Copyright © LIBRIS - National Library Systems
- LIBRIS.kb.se
